THE HEALTHCARE NEWS DIARIES

Britain’s drug regulator authorized the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an impartial watchdog company claimed the procedure isn’t well worth the Expense to taxpayersLocal weather modify, civil conflict and expanding resistance to insecticides and treatment plans are all contributing to